Switzerland Biotechnology & Medical Research

Addex Therapeutics Ltd (ADXN)

Addex Therapeutics Ltd has recorded no insider trading activity within the last ninety days. The most recent transactions occurred in early 2018 and late 2017, both involving share purchases. Given that these events transpired over three years ago, there is no current data regarding executive equity movements to report.

No insider activity signal

Not featured in screeners

Featured in screeners

No insider activity signal

Not featured in screeners

Ticker: ADXN Exchange: SWX

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signals

0 activity signals detected for Addex Therapeutics Ltd

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Executive Director / Officer

Transaction date 28 Mar 2018

Purchase

Price

175.62

Quantity 78,915

Value CHF3,544,326

Comments Filing

Executive Director / Officer

Transaction date 23 Dec 2017

Purchase

Price

341.07

Quantity 69,609

Value CHF1,969,798

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value	Details
2018-03-28	2018-03-28	B Purchase	Executive Director / Officer	78,915 175.62 CHF3,544,326	78,915	175.62	CHF3,544,326
2017-12-23	2017-12-23	B Purchase	Executive Director / Officer	69,609 341.07 CHF1,969,798	69,609	341.07	CHF1,969,798